University of Dundee

CLS Impact and Outreach

Business Leadership Award for Professor Andrew Hopkins

Professor Andrew Hopkins, of the College of Life Sciences at the University of Dundee, has been named one of this year’s winners at the prestigious Scottish Enterprise Life Sciences Awards.
At a ceremony in Edinburgh last night Professor Hopkins was handed the award for Life Sciences Entrepreneurial Business Leadership.
Andrew is the founder and CEO of ex scientia, a University of Dundee spin-out company which is pioneering medicines tailored to polypharmacology for a wide range of human diseases where improved efficacy is required.

Drug Discovery Unit and McLean Lab formalise agreement with Pfizer Inc. to research potential new therapies for the treatment of Cystic Fibrosis

The University of Dundee has entered into a Research Program Agreement with Pfizer Inc. to jointly conduct research that may lead to potential novel treatments for Cystic Fibrosis.
The project will be carried out as part of Pfizer’s Rare Disease Consortium and builds on a program of research within the laboratory of Professor Irwin McLean, Head of Molecular Medicine at Dundee, and the University’s Drug Discovery Unit.

Material Concerns: LifeSpace exhibition explores consent in donation and use of human tissue in life, art and scientific research

The use of human materials for research, donation and art will be the focus of the second exhibition at LifeSpace, the new research-driven science art gallery which is a collaborative partnership between researchers from Duncan of Jordanstone College of Art and Design and researchers from the College of Life Sciences. 

Antimicrobial resistance affects everyone - come and join the discussion at the Nesta Spotlight on the Longitude Prize 2014, Wed 28 January, 6pm Large Lecture Theatre

Question: Should I be taking an interest in antimicrobial resistance?? 
Answer: Yes!

"Failure to tackle drug-resistant infections will lead to at least 10 million extra deaths a year and cost the global economy up to $100trillion (£64 trillion) by 2050.” 

Jim O'Neill, former Goldman Sachs chief economist, chair of a high-level report commissioned by the UK Government in 2014. 


Sir Philip Cohen and Professor Mike Ferguson feature in the Courier's Impact 100

This week The Courier ran its Impact 100 list of the most influential individuals and organisations from across Tayside and Fife in 2014.
The University of Dundee is strongly represented in the poll, with 17 placings and listings for staff, students, graduates, honorary graduates and other friends of the University below.
Two of the most prominent members of the College of Life Sciences, Professor Sir Philip Cohen and Professor Mike Ferguson feature on the list as well as long-time CLS associate Professor Sue Black of CAHID.

CLS researcher’s image voted winner of BBSRC `Images with Impact’

A stunning image produced by a University of Dundee researcher has been voted the winner of the `Images with Impact’ competition.

The image produced by Ian Newton, from the College of Life Sciences at Dundee, wowed visitors to the Great British Bioscience Festival. It showed microtubules but provoked comparisons with Edvard Munch’s famous painting `The Scream’. It was one of eighteen shortlisted pictures on which the public were asked to vote.

CLS spin-out ex scientia named Courier Young Business of the Year 2014

Life Sciences spin-out company ex scientia has been named Young Business of the Year at the second annual Courier Business Awards which were held at Fairmont St Andrews on November 14.

600 local business leaders from Tayside, Fife and Perthshire attended the ceremony at which a total of 14 awards were handed out by host and television comedian Hugh Dennis, including 12 sector-specific prizes covering all aspects of the diverse economy of east central  Scotland.

Dundee iGEM team scores a hat-trick at world jamboree

A team of students from the University of Dundee has won an unprecedented hat-trick of major prizes at the iGEM world jamboree in Boston for their project to develop `The Lung Ranger’, a device to help combat some of the effects of cystic fibrosis.

iGEM – the International Genetically Engineered Machine competition – asks students to tackle a real world problem by designing and building a new device or system from a kit of biological parts.

Ciulli Lab's bump-and-hole approach leads to protein breakthrough

A major breakthrough by scientists at the University of Dundee in the study of a set of human proteins has the potential to unlock a huge new area of drug discovery for many diseases including cancer and inflammatory conditions.
The research team led by Dr Alessio Ciulli in the College of Life Sciences at Dundee have developed a new method of selectively targeting the proteins known as BET bromodomains using small molecules.